SAGA Diagnostics AB is a Lund based personalized cancer diagnostics and disease monitoring company focused on molecular genetic analyses of a powerful cancer biomarker: circulating tumor DNA (ctDNA). SAGA has since its foundation in 2016 established partnerships with leading hospitals and big pharma and has also achieved both ISO17025 and ISO13485 accreditation.
SAGAsign® is a sequencing based method which is ideal for monitoring of response to therapy, MRD (minimal residual disease), and recurrences. SAGAsafe® is an ultrasensitive ddPCR method for identification of mutations in liquid biopsies such as blood samples.
